Items tagged with Treatment
Urgent need to register essential medicines for the treatment and prevention of TB in South Africa (post with simple image)
Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.
Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline (post with simple image)
Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.
An Activist’s Guide to Bedaquiline (Sirturo) (post with simple image)
The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.
Advocates call on Otsuka to reduce the price of delamanid (post with simple image)
Advocates ask Otsuka to lower the price of delamanid in line with Médecins sans Frontières target regimen cost of $500.
Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality (post with simple image)
Activists urge international donors and country governments to ensure access to quality health products as domestic financing policies push programs to the edge of procurement cliff.
Médecins Sans Frontières calls on Johnson & Johnson to cut key TB drug price in half (post with simple image)
Warns high prices of TB drugs restrict people's access to best drug-resistant TB treatment.
Activists urge National TB Programs and treatment providers to discontinue use of harmful injectable agents in TB treatment (post with simple image)
In a symbolic display, activists invited conference participants to discard the injectable agents and commit to rapidly scaling up access to safer, more effective medicine.
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day (post with simple image)
Activists demand that Johnson & Johnson cut the price of bedaquiline in half, to no higher than $1 per day—$32 per person per month—double the price that researchers estimate bedaquiline could be sold for a profit.
Urgent need to address the Global Fund procurement cliff for TB (post with simple image)
Activists urge the Global Fund and donors to take prompt action to address the grave risks posed to countries that are rapidly shifting from pooled procurement of TB medicines and commodities.
HIV and TB treatment at risk as countries gradually lose Global Fund support (post with simple image)
Médecins Sans Frontières calls on Global Fund Board to make urgent changes to prevent drug stock-outs and quality issues.
Page 81 of 85 · Total posts: 0←First 80 81 82 Last→